Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | ($249.2M) | $169.7M | $130.2M | $67.8M | ($615.2M) | ($4,426.2K) | ($35.0M) | $222.0M | $66.0M | ($19.4M) | $304.0M | $317.2M | $135.2M | $58.5M |
Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 4,949.9 0.0% | 4,641.5 (6.2%) | 4,642.6 0.0% | 4,870.7 4.9% | 5,721.8 17.5% | 5,248.4 (8.3%) | 5,913.9 12.7% | 6,713.7 13.5% | 6,612.4 (1.5%) | 5,574.8 (15.7%) | 7,276.3 30.5% | 8,556.9 17.6% | 7,828.1 (8.5%) | 7,659.7 (2.2%) |
Cost of Goods Sold (COGS) | 4,508.6 | 4,026.9 | 4,017.0 | 4,229.0 | 5,222.2 | 4,677.4 | 5,305.2 | 6,078.5 | 5,938.5 | 5,015.4 | 6,491.0 | 7,848.7 | 7,060.3 | 6,680.2 |
% margin | 441.3 8.9% | 614.6 13.2% | 625.7 13.5% | 641.7 13.2% | 499.7 8.7% | 571.0 10.9% | 608.7 10.3% | 635.2 9.5% | 673.9 10.2% | 559.4 10.0% | 785.4 10.8% | 708.2 8.3% | 767.8 9.8% | 979.5 12.8% |
Operating Expenses | 346.6 | 318.9 | 326.8 | 316.2 | 310.9 | 316.5 | 320.7 | 338.9 | 362.7 | 315.1 | 351.3 | 347.8 | 403.4 | 378.0 |
Research & Development Expenses (R&D) | 45.9 | 46.3 | 47.8 | 50.5 | 38.9 | 35.4 | 40.7 | 47.2 | 53.7 | 44.5 | 46.1 | 50.6 | 57.3 | 51.2 |
Selling, General & Administrative Expenses (SG&A) | 300.7 | 272.6 | 279.0 | 265.7 | 272.0 | 281.1 | 280.1 | 291.6 | 309.0 | 270.6 | 305.2 | 297.2 | 343.9 | 326.9 |
% margin | (87.7) (1.8%) | 330.4 7.1% | 277.6 6.0% | 199.3 4.1% | (473.0) (8.3%) | 272.2 5.2% | 362.5 6.1% | 477.0 7.1% | 285.5 4.3% | 142.7 2.6% | 572.5 7.9% | 352.0 4.1% | 364.4 4.7% | 601.5 7.9% |
Interest Income | 2.8 | 5.1 | 22.6 | 0.0 | 78.8 | 5.5 | 7.9 | 8.3 | 155.6 | 149.6 | 137.2 | 105.4 | 17.3 | 0.0 |
Interest Expense | 48.7 | 82.3 | 66.4 | 38.5 | 250.9 | 177.0 | 274.4 | 175.9 | 195.9 | 181.5 | 197.5 | 138.0 | 124.4 | 0.0 |
Pre-tax Income | (284.0) | 243.0 | 179.3 | 120.9 | (648.5) | 71.9 | 55.3 | 262.1 | 91.8 | (38.8) | 374.9 | 213.9 | 211.9 | 141.0 |
% effective tax rate | (47.3) 16.7% | 60.4 24.9% | 51.8 28.9% | 49.2 40.7% | (35.5) 5.5% | 76.4 106.2% | 90.3 163.3% | 37.8 14.4% | 20.1 22.0% | (19.4) 50.0% | 65.1 17.4% | (110.6) (51.7%) | 72.5 34.2% | 78.3 55.6% |
% margin | (249.2) (5.0%) | 169.7 3.7% | 130.2 2.8% | 67.8 1.4% | (615.2) (10.8%) | (4.4) (0.1%) | (35.0) (0.6%) | 222.0 3.3% | 66.0 1.0% | (19.4) (0.3%) | 304.0 4.2% | 317.2 3.7% | 135.2 1.7% | 58.5 0.8% |
EPS | (2.42) | 1.74 | 1.33 | 0.64 | (5.85) | (0.04) | (0.32) | 1.65 | 0.48 | (0.14) | 2.25 | 2.17 | 0.91 | 0.40 |
Diluted EPS | (2.42) | 1.74 | 1.32 | 0.64 | (5.83) | (0.04) | (0.32) | 1.61 | 0.46 | (0.14) | 2.15 | 2.13 | 0.91 | 0.40 |
% margin | (44.5) (0.9%) | 309.9 6.7% | 288.3 6.2% | 373.3 7.7% | (473.0) (8.3%) | 442.6 8.4% | 527.4 8.9% | 420.3 6.3% | 551.9 8.3% | 518.3 9.3% | 903.6 12.4% | 633.3 7.4% | 654.2 8.4% | 574.3 7.5% |
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
As of today, Constellium SE's last 12-month Net Income is $58.5M, based on the financial report for Dec 31, 2024 (Q4’2024).
Over the last year, Constellium SE's Net Income growth was (56.7%). The average annual Net Income growth rates for Constellium SE have been (37.0%) over the past three years, (2.7%) over the past five years.
Over the last year, Constellium SE's Net Income growth was (56.7%), which is lower than industry growth of 27.9%. It indicates that Constellium SE's Net Income growth is Bad.